Danay Saavedra

719 total citations
30 papers, 389 citations indexed

About

Danay Saavedra is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Danay Saavedra has authored 30 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Oncology and 8 papers in Infectious Diseases. Recurrent topics in Danay Saavedra's work include Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (7 papers) and COVID-19 Clinical Research Studies (6 papers). Danay Saavedra is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (7 papers) and COVID-19 Clinical Research Studies (6 papers). Danay Saavedra collaborates with scholars based in Cuba, United States and Belgium. Danay Saavedra's co-authors include Tania Crombet, Agustín Lage, Beatriz García Verdecia, Zaima Mazorra, Patricia Lorenzo-Luaces, Elia Neninger, Nuris Ledón, Laura J. Niedernhofer, Daniela Frasca and Wim Vanden Berghe and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Danay Saavedra

27 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danay Saavedra Cuba 10 164 134 86 52 52 30 389
Paula Araya United States 10 136 0.8× 54 0.4× 77 0.9× 26 0.5× 36 0.7× 20 321
Emma Erlich United States 9 154 0.9× 84 0.6× 81 0.9× 24 0.5× 93 1.8× 15 455
Sapana Kadel United States 4 200 1.2× 99 0.7× 73 0.8× 45 0.9× 48 0.9× 6 368
Caterina E. Faliti United States 7 258 1.6× 46 0.3× 144 1.7× 15 0.3× 70 1.3× 10 462
Ziyi Chen China 7 116 0.7× 54 0.4× 125 1.5× 26 0.5× 40 0.8× 18 322
Nathan Luebbering United States 8 133 0.8× 43 0.3× 128 1.5× 30 0.6× 44 0.8× 33 353
Kristie Wood United Kingdom 9 250 1.5× 82 0.6× 93 1.1× 15 0.3× 30 0.6× 9 408
Cheng Hiang Lee Australia 6 170 1.0× 69 0.5× 59 0.7× 23 0.4× 11 0.2× 12 329
Jamal Zaini Indonesia 10 126 0.8× 89 0.7× 60 0.7× 66 1.3× 63 1.2× 38 329
Leuridan Cavalcante Torres Brazil 9 56 0.3× 53 0.4× 58 0.7× 36 0.7× 57 1.1× 40 268

Countries citing papers authored by Danay Saavedra

Since Specialization
Citations

This map shows the geographic impact of Danay Saavedra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danay Saavedra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danay Saavedra more than expected).

Fields of papers citing papers by Danay Saavedra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danay Saavedra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danay Saavedra. The network helps show where Danay Saavedra may publish in the future.

Co-authorship network of co-authors of Danay Saavedra

This figure shows the co-authorship network connecting the top 25 collaborators of Danay Saavedra. A scholar is included among the top collaborators of Danay Saavedra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danay Saavedra. Danay Saavedra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
T, Marco González, Danay Saavedra, Tania Crombet, et al.. (2025). Mucosal Vaccination Against SARS-CoV-2 Using Human Probiotic Bacillus subtilis Spores as an Adjuvant Induces Potent Systemic and Mucosal Immunity. Vaccines. 13(7). 772–772. 1 indexed citations
2.
Mittal, Rahul, et al.. (2025). Inflammasome activation and accelerated immune aging in autoimmune disorders. Frontiers in Aging. 6. 1688060–1688060.
3.
Sánchez, Lizet, et al.. (2024). Safety and effectiveness of CIMAvax-EGF administered in community polyclinics. Frontiers in Oncology. 13. 1287902–1287902. 8 indexed citations
4.
Ledón, Nuris, et al.. (2023). Immunosenescence and inflammatory markers in Cuban centenarians: implications for survival. Aging Clinical and Experimental Research. 35(11). 2839–2842. 5 indexed citations
5.
Early, Amy, Mary E. Reid, Kelvin H. Lee, et al.. (2023). Final results from a phase II trial of CIMAvax-EGF and nivolumab as second-line (2L) therapy after platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 41(16_suppl). 9135–9135. 7 indexed citations
6.
Saavedra, Danay, Nir Barzilai, Calogero Caruso, et al.. (2023). Aging and chronic inflammation: highlights from a multidisciplinary workshop. Immunity & Ageing. 20(1). 25–25. 76 indexed citations
7.
Ledón, Nuris, et al.. (2022). Association among Terminally Differentiated T Cells, Frailty, and Dependency in a Group of Cuban Centenarians. Gerontology. 69(3). 239–248. 9 indexed citations
8.
Catalá, Mauricio, Patricia Lorenzo-Luaces, Raúl Ramos, et al.. (2022). Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy. Frontiers in Oncology. 12. 823287–823287. 5 indexed citations
9.
Saavedra, Danay, et al.. (2022). Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody. Immunology Letters. 251-252. 1–8. 2 indexed citations
10.
Figueredo, Carlos Marcelo, Mayra Ramos, Danay Saavedra, et al.. (2021). An Anti-CD6 Antibody for the Treatment of COVID-19 Patients with Cytokine-Release Syndrome: Report of Three Cases. Immunotherapy. 13(4). 289–295. 8 indexed citations
11.
Crombet, Tania, et al.. (2021). Reposicionamiento del anticuerpo monoclonal humanizado anti-CD6 itolizumab en el tratamiento de pacientes con COVID-19. SHILAP Revista de lepidopterología.
12.
Lorenzo-Luaces, Patricia, Elia Neninger, Mauricio Catalá, et al.. (2021). Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer. Cancer Immunology Immunotherapy. 70(6). 1735–1743. 8 indexed citations
13.
Ramos, Mayra, Danay Saavedra, Zaima Mazorra, et al.. (2020). Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19. Gerontology. 66(6). 553–561. 22 indexed citations
14.
Lorenzo-Luaces, Patricia, Lizet Sánchez, Danay Saavedra, et al.. (2020). Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients. BMC Cancer. 20(1). 772–772. 7 indexed citations
15.
Saavedra, Danay, et al.. (2018). Manipulación de la inmunosenescencia. Revista Cubana de Hematología, Inmunología y Hemoterapia. 34(1). 33–41. 1 indexed citations
16.
Dy, Grace K., Marvin Reid, Kwanghyuk Lee, et al.. (2018). P2.04-26 Interim Results from a Phase I/II Trial of Nivolumab in Combination with CIMAvax-EGF as Second-Line Therapy in Advanced NSCLC. Journal of Thoracic Oncology. 13(10). S740–S740. 2 indexed citations
17.
Saavedra, Danay, Elia Neninger, Carmen Viada, et al.. (2018). CIMAvax-EGF: Toward long-term survival of advanced NSCLC. Seminars in Oncology. 45(1-2). 34–40. 17 indexed citations
18.
Saavedra, Danay, Beatriz García Verdecia, & Agustín Lage. (2017). T Cell Subpopulations in Healthy Elderly and Lung Cancer Patients: Insights from Cuban Studies. Frontiers in Immunology. 8. 146–146. 18 indexed citations
19.
Verdecia, Beatriz García, et al.. (2013). Immunosenescence and gender: a study in healthy Cubans. Immunity & Ageing. 10(1). 16–16. 18 indexed citations
20.
Fernández-Morán, Jesús, Danay Saavedra, J.L. Ruiz-de-la-Torre, & Xavier Manteca. (2004). Stress in wild-caught Eurasian otters (Lutra lutra): effects of a long-acting neuroleptic and time in captivity. Animal Welfare. 13(2). 143–149. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula Araya Breakdown of academic impact, for papers by Emma Erlich Breakdown of academic impact, for papers by Sapana Kadel Breakdown of academic impact, for papers by Caterina E. Faliti Breakdown of academic impact, for papers by Ziyi Chen Breakdown of academic impact, for papers by Nathan Luebbering Breakdown of academic impact, for papers by Kristie Wood Breakdown of academic impact, for papers by Cheng Hiang Lee Breakdown of academic impact, for papers by Jamal Zaini Breakdown of academic impact, for papers by Leuridan Cavalcante Torres
Rankless by CCL
2026